AQR Capital Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,714
| Closed | -$93.8K | – | 3346 |
|
|
2025
Q1 | $93.8K | Buy |
8,714
+7,716
| +773% | +$83K | ﹤0.01% | 3024 |
|
|
2024
Q4 | $12.8K | Sell |
998
-4,858
| -83% | -$62.2K | ﹤0.01% | 2853 |
|
|
2024
Q3 | $162K | Buy |
+5,856
| New | +$162K | ﹤0.01% | 2608 |
|
|
2024
Q2 | – | Sell |
-2,212
| Closed | -$98.7K | – | 2645 |
|
|
2024
Q1 | $98.7K | Buy |
2,212
+700
| +46% | +$31.2K | ﹤0.01% | 2341 |
|
|
2023
Q4 | $58.7K | Buy |
1,512
+33
| +2% | +$1.28K | ﹤0.01% | 2305 |
|
|
2023
Q3 | $43.5K | Buy |
+1,479
| New | +$43.5K | ﹤0.01% | 2289 |
|